AU2002333193A1 - A pharmaceutical composition for dermal application - Google Patents

A pharmaceutical composition for dermal application

Info

Publication number: AU2002333193A1
Authority: AU; Australia
Prior art keywords: pharmaceutical composition; dermal application; dermal; application; pharmaceutical
Prior art date: 2001-08-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002333193A

Inventor

Erik Johannes Didriksen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Leo Pharma AS

Original Assignee

Leo Pharma AS

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-15

Filing date

2002-08-15

Publication date

2003-03-03

2002-08-15 Application filed by Leo Pharma AS filed Critical Leo Pharma AS

2003-03-03 Publication of AU2002333193A1 publication Critical patent/AU2002333193A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AU2002333193A 2001-08-15 2002-08-15 A pharmaceutical composition for dermal application Abandoned AU2002333193A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US31209901P	2001-08-15	2001-08-15
US60/312,099		2001-08-15
PCT/DK2002/000538 WO2003015789A2 (en)	2001-08-15	2002-08-15	A pharmaceutical composition for dermal application

Publications (1)

Publication Number	Publication Date
AU2002333193A1 true AU2002333193A1 (en)	2003-03-03

Family

ID=23209876

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002333193A Abandoned AU2002333193A1 (en)	2001-08-15	2002-08-15	A pharmaceutical composition for dermal application

Country Status (2)

Country	Link
AU (1)	AU2002333193A1 (en)
WO (1)	WO2003015789A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN105121439A (en)	2013-02-19	2015-12-02	辉瑞公司	Azabenzimidazole compounds as inhibitors of pde4 isozymes for the treatment of cns and other disorders
EP3172210B1 (en)	2014-07-24	2020-01-15	Pfizer Inc	Pyrazolopyrimidine compounds
SG11201700243YA (en)	2014-08-06	2017-02-27	Pfizer	Imidazopyridazine compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8906792D0 (en) *	1989-03-23	1989-05-10	Beecham Wuelfing Gmbh & Co Kg	Treatment and compounds
IT1277338B1 (en) *	1995-07-25	1997-11-10	Poli Ind Chimicia S P A	PHARMACEUTICAL COMPOSITIONS OF CYCLOSPORINE OR OTHER PEPTIDE SUBSTANCES
DE69840426D1 (en) *	1997-11-10	2009-02-12	Strakan Int Ltd	Penetration-promoting and irritation-reducing systems with testosterone
PT1202954E (en) *	1999-07-16	2004-02-27	Leo Pharma As	NEW AMINOBENZOFENONAS

2002
- 2002-08-15 AU AU2002333193A patent/AU2002333193A1/en not_active Abandoned
- 2002-08-15 WO PCT/DK2002/000538 patent/WO2003015789A2/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2003015789A3 (en)	2004-03-04
WO2003015789A2 (en)	2003-02-27

Similar Documents

Publication	Publication Date	Title
AU781269C (en)	2006-11-30	Pharmaceutical compositions
AU2002248377A1 (en)	2002-09-12	A controlled release pharmaceutical composition
AU2002313236A1 (en)	2003-05-15	Medicinal compositions
AU2001250420A1 (en)	2001-10-23	Pharmaceutical compositions
AU2001274307A1 (en)	2002-01-02	Pharmaceutical compositions
AU2002302147A1 (en)	2003-06-12	Pharmaceutical composition
AU2002257582A1 (en)	2002-09-04	Pharmaceutical formulation
AU2002258221A1 (en)	2003-05-08	Medicinal composition
AU2002255692A1 (en)	2002-09-24	A cream-t0-powder dermatological composition
AU2001290239A1 (en)	2002-04-02	Medicinal composition
AU2001273919A1 (en)	2001-10-23	Pharmaceutical compositions
AU4085201A (en)	2001-09-24	Pharmaceutical composition
AU2003284460A1 (en)	2004-06-23	Medicinal composition
AU2003208621A1 (en)	2003-09-16	A pharmaceutical composition
AU2003280799A1 (en)	2004-06-15	Medicinal composition
AU2002333193A1 (en)	2003-03-03	A pharmaceutical composition for dermal application
AU2002354460A1 (en)	2003-07-09	Medicinal composition
AU3586401A (en)	2001-09-17	Pharmaceutical composition
AU2001292578A1 (en)	2002-04-15	Pharmaceutical compounds
AU2002351722A1 (en)	2003-06-10	A pharmaceutical composition for dermal application
AU2001278705A1 (en)	2002-02-25	Pharmaceutical composition
AU2003280678A1 (en)	2004-05-25	Medicinal composition
AUPR529701A0 (en)	2001-06-21	Pharmaceutical composition
AU2002342940A1 (en)	2003-06-10	New pharmaceutical compounds
AU2001285737A1 (en)	2001-12-24	Pharmaceutical compositions

Legal Events

Date	Code	Title	Description
2004-05-06	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase